IVDMIA
In the Instand-NGS4P program, a group of seven European hospitals are encouraging technology vendors to innovate by offering a path to IVDR compliance and a wide market for new products.
Study Suggesting Breast Cancer Patients at Low Genomic Risk Could Avoid Chemotherapy Criticized
One group pointed out differences between study group characteristics, while the other wondered about the role of patient preference.
The firm believes the diagnostics industry has not done a good job of communicating the value of medical tests to payors.
Congressional Subcommittee Questions Legality of FDA's RUO Guidance, Calls for Agency Response
Premium
Members of a US House of Representatives subcommittee have called on the US Food and Drug Administration to respond to "significant concern" regarding the agency's draft guidance document on research-use-only and investigational-use-only diagnostic products.
Agendia Signs Contract with Blue Shield of California
NEW YORK (GenomeWeb News) – Agendia today said that it has signed a contract with Blue Shield of California, making it an in-network provider.
Nov 9, 2011
Jul 13, 2011
Jan 21, 2011
Vermillion Plans to Raise up to $17.3M
Oct 19, 2010
Humana to Cover Agendia's MammaPrint
Jun 23, 2010
Jun 16, 2010
Apr 20, 2010
Ferrer to be Agendia's Latin America Distributor
Mar 12, 2010
Medicare to Cover Vermillion Ovarian Cancer Test
Feb 9, 2010
NY State Grants Clinical Lab Permit to Agendia
Sep 16, 2009
Aug 12, 2009
Jun 10, 2009